Zensar Technologies Limited provided an update regarding the merger of its US-based 100% step-down subsidiaries with Zensar Technologies Inc., USA, a material wholly owned subsidiary of the company. This disclosure is in continuation of the company's previous communication dated July 29, 2026, regarding the Board of Directors' in-principle approval for the merger.
The company completed all requisite filings for the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. with the relevant local authorities/state agencies on July 30, 2026. The merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. will become effective from August 1, 2026. The company received intimation of this completion at 03:00 a.m. (IST) on July 31, 2026.
Regarding the merger of M3BI LLC with Zensar Technologies Inc., the company stated that the filings are currently in progress as of July 31, 2026.
The communication was signed by Anand Champalal Daga, Company Secretary, and was addressed to both BSE Limited and National Stock Exchange of India Limited.